Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Houlihan Lokey (HLI) Cash & Equivalents (2016 - 2025)

Houlihan Lokey has reported Cash & Equivalents over the past 12 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 32.17% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 32.17%, while the annual FY2025 figure was $971.0 million, 34.63% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.1 billion at Houlihan Lokey, up from $923.6 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.1 billion in Q4 2021 and troughed at $449.7 million in Q2 2024.
  • A 5-year average of $730.7 million and a median of $751.7 million in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 122.64% in 2021 and later plummeted 48.1% in 2022.
  • Year by year, Cash & Equivalents stood at $1.1 billion in 2021, then crashed by 48.1% to $549.4 million in 2022, then increased by 1.11% to $555.5 million in 2023, then skyrocketed by 43.89% to $799.3 million in 2024, then soared by 32.17% to $1.1 billion in 2025.
  • Business Quant data shows Cash & Equivalents for HLI at $1.1 billion in Q4 2025, $923.6 million in Q3 2025, and $793.8 million in Q2 2025.